$8.9M Bioness Stockholder Settlement, Were You Cut Out of a Fair Price When They Sold the Company? Claim Before April 24
Bioness Inc. minority stockholders filed a class action in Delaware’s Court of Chancery alleging they were shortchanged when the orthopedic device company sold to Bioventus Inc. for $110 million in March 2021. Plaintiffs argued the deal was engineered to favor Bioness’s controlling creditor at the expense of minority stockholders. A proposed $8,900,000 settlement now awaits…
